Human Biomonitoring of Mycotoxins in Blood, Plasma and Serum in Recent Years: A Review

Overview

Journal Toxins (Basel)

Publisher MDPI

Specialty Toxicology

Date 2020 Mar 4

PMID 32121036

Citations 39

Authors

Beatriz Arce-Lopez

Elena Lizarraga

Ariane Vettorazzi

Elena Gonzalez-Penas

Affiliations

Soon will be listed here.

Abstract

This manuscript reviews the state-of-the-art regarding human biological monitoring (HBM) of mycotoxins in plasma serum and blood samples. After a comprehensive and systematic literature review, with a focus on the last five years, several aspects were analyzed and summarized: a) the biomarkers analyzed and their encountered levels, b) the analytical methodologies developed and c) the relationship between biomarker levels and some illnesses. In the literature reviewed, aflatoxin B1-lysine (AFB1-lys) and ochratoxin A (OTA) in plasma and serum were the most widely studied mycotoxin biomarkers for HBM. Regarding analytical methodologies, a clear increase in the development of methods for the simultaneous determination of multiple mycotoxins has been observed. For this purpose, the use of liquid chromatography (LC) methodologies, especially when coupled with tandem mass spectrometry (MS/MS) or high resolution mass spectrometry (HRMS), has grown. A high percentage of the samples analyzed for OTA or aflatoxin B1 (mostly as AFB1-lys) in the reviewed papers were positive, demonstrating human exposure to mycotoxins. This review confirms the importance of mycotoxin human biomonitoring and highlights the important challenges that should be faced, such as the inclusion of other mycotoxins in HBM programs, the need to increase knowledge of mycotoxin metabolism and toxicokinetics, and the need for reference materials and new methodologies for treating samples. In addition, guidelines are required for analytical method validation, as well as equations to establish the relationship between human fluid levels and mycotoxin intake.

Citing Articles

Maize consumption and circulating aflatoxin levels in Mexican middle- and older-aged adults: a cross-sectional analysis.

Solis-Martinez O, Monge A, Groopman J, McGlynn K, Romero-Martinez M, Romero M Am J Clin Nutr. 2024; 121(2):454-462.

PMID: 39710096 PMC: 11863335. DOI: 10.1016/j.ajcnut.2024.12.018.

Ochratoxin A in food commodities: A review of occurrence, toxicity, and management strategies.

Banahene J, Ofosu I, Odai B, Lutterodt H, Agyemang P, Ellis W Heliyon. 2024; 10(20):e39313.

PMID: 39640601 PMC: 11620267. DOI: 10.1016/j.heliyon.2024.e39313.

Ochratoxin A Status at Birth Is Associated with Reduced Birth Weight and Ponderal Index in Rural Burkina Faso.

Bastos-Moreira Y, Argaw A, Di Palma G, Dailey-Chwalibog T, El-Hafi J, Ouedraogo L J Nutr. 2024; 155(1):260-269.

PMID: 39393495 PMC: 11795690. DOI: 10.1016/j.tjnut.2024.10.015.

Multiple mycotoxin exposure assessment through human biomonitoring in an esophageal cancer case-control study in the Arsi-Bale districts of Oromia region of Ethiopia.

Mulisa G, Pero-Gascon R, McCormack V, Bisanz J, Talukdar F, Abebe T Int J Hyg Environ Health. 2024; 263:114466.

PMID: 39306897 PMC: 11635094. DOI: 10.1016/j.ijheh.2024.114466.

The Potential of Multi-Screening Methods and Omics Technologies to Detect Both Regulated and Emerging Mycotoxins in Different Matrices.

Lapris M, Errico M, Rocchetti G, Gallo A Foods. 2024; 13(11).

PMID: 38890974 PMC: 11171533. DOI: 10.3390/foods13111746.

References

Turner P, Flannery B, Isitt C, Ali M, Pestka J . The role of biomarkers in evaluating human health concerns from fungal contaminants in food. Nutr Res Rev. 2012; 25(1):162-79. DOI: 10.1017/S095442241200008X. View

Capriotti A, Caruso G, Cavaliere C, Foglia P, Samperi R, Lagana A . Multiclass mycotoxin analysis in food, environmental and biological matrices with chromatography/mass spectrometry. Mass Spectrom Rev. 2011; 31(4):466-503. DOI: 10.1002/mas.20351. View

Alhamoud Y, Yang D, Fiati Kenston S, Liu G, Liu L, Zhou H . Advances in biosensors for the detection of ochratoxin A: Bio-receptors, nanomaterials, and their applications. Biosens Bioelectron. 2019; 141:111418. DOI: 10.1016/j.bios.2019.111418. View

Knutsen H, Barregard L, Bignami M, Bruschweiler B, Ceccatelli S, Cottrill B . Appropriateness to set a group health-based guidance value for fumonisins and their modified forms. EFSA J. 2020; 16(2):e05172. PMC: 7009576. DOI: 10.2903/j.efsa.2018.5172. View

Streit E, Schatzmayr G, Tassis P, Tzika E, Marin D, Taranu I . Current situation of mycotoxin contamination and co-occurrence in animal feed--focus on Europe. Toxins (Basel). 2012; 4(10):788-809. PMC: 3496989. DOI: 10.3390/toxins4100788. View

Mahfuz M, Alam M, Fahim S, Gazi M, Raihan M, Hossain M . Aflatoxin exposure in children living in Mirpur, Dhaka: data from MAL-ED companion study. J Expo Sci Environ Epidemiol. 2018; 29(5):655-662. PMC: 6760605. DOI: 10.1038/s41370-018-0066-5. View

Degen G, Ali N, Gundert-Remy U . Preliminary data on citrinin kinetics in humans and their use to estimate citrinin exposure based on biomarkers. Toxicol Lett. 2017; 282:43-48. DOI: 10.1016/j.toxlet.2017.10.006. View

Ferri F, Brera C, De Santis B, Fedrizzi G, Bacci T, Bedogni L . Survey on Urinary Levels of Aflatoxins in Professionally Exposed Workers. Toxins (Basel). 2017; 9(4). PMC: 5408191. DOI: 10.3390/toxins9040117. View

Kruve A, Rebane R, Kipper K, Oldekop M, Evard H, Herodes K . Tutorial review on validation of liquid chromatography-mass spectrometry methods: part II. Anal Chim Acta. 2015; 870:8-28. DOI: 10.1016/j.aca.2015.02.016. View

10.

Furey A, Moriarty M, Bane V, Kinsella B, Lehane M . Ion suppression; a critical review on causes, evaluation, prevention and applications. Talanta. 2013; 115:104-22. DOI: 10.1016/j.talanta.2013.03.048. View

11.

Cramer B, Osteresch B, Munoz K, Hillmann H, Sibrowski W, Humpf H . Biomonitoring using dried blood spots: detection of ochratoxin A and its degradation product 2'R-ochratoxin A in blood from coffee drinkers. Mol Nutr Food Res. 2015; 59(9):1837-43. PMC: 4744763. DOI: 10.1002/mnfr.201500220. View

12.

Scholl P, Groopman J . Long-term stability of human aflatoxin B1 albumin adducts assessed by isotope dilution mass spectrometry and high-performance liquid chromatography-fluorescence. Cancer Epidemiol Biomarkers Prev. 2008; 17(6):1436-9. PMC: 2586885. DOI: 10.1158/1055-9965.EPI-07-2926. View

13.

Knutsen H, Barregard L, Bignami M, Bruschweiler B, Ceccatelli S, Cottrill B . Appropriateness to set a group health based guidance value for T2 and HT2 toxin and its modified forms. EFSA J. 2020; 15(1):e04655. PMC: 7010130. DOI: 10.2903/j.efsa.2017.4655. View

14.

Arce-Lopez B, Lizarraga E, Flores-Flores M, Irigoyen A, Gonzalez-Penas E . Development and validation of a methodology based on Captiva EMR-lipid clean-up and LC-MS/MS analysis for the simultaneous determination of mycotoxins in human plasma. Talanta. 2019; 206:120193. DOI: 10.1016/j.talanta.2019.120193. View

15.

Aydin M, Aydin S, Bacanli M, Basaran N . Aflatoxin levels in chronic hepatitis B patients with cirrhosis or hepatocellular carcinoma in Balıkesir, Turkey. J Viral Hepat. 2015; 22(11):926-35. DOI: 10.1111/jvh.12410. View

16.

Slobodchikova I, Vuckovic D . Liquid chromatography - high resolution mass spectrometry method for monitoring of 17 mycotoxins in human plasma for exposure studies. J Chromatogr A. 2018; 1548:51-63. DOI: 10.1016/j.chroma.2018.03.030. View

17.

Zhang K, Wong J, Krynitsky A, Trucksess M . Determining mycotoxins in baby foods and animal feeds using stable isotope dilution and liquid chromatography tandem mass spectrometry. J Agric Food Chem. 2014; 62(36):8935-43. DOI: 10.1021/jf503943r. View

18.

Moher D, Liberati A, Tetzlaff J, Altman D . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009; 6(7):e1000097. PMC: 2707599. DOI: 10.1371/journal.pmed.1000097. View

19.

Wang J, Abubaker S, He X, Sun G, Strickland P, Groopman J . Development of aflatoxin B(1)-lysine adduct monoclonal antibody for human exposure studies. Appl Environ Microbiol. 2001; 67(6):2712-7. PMC: 92929. DOI: 10.1128/AEM.67.6.2712-2717.2001. View

20.

McCoy L, Scholl P, Sutcliffe A, Kieszak S, Powers C, Rogers H . Human aflatoxin albumin adducts quantitatively compared by ELISA, HPLC with fluorescence detection, and HPLC with isotope dilution mass spectrometry. Cancer Epidemiol Biomarkers Prev. 2008; 17(7):1653-7. DOI: 10.1158/1055-9965.EPI-07-2780. View